Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Extended Carboplatin Infusion on Hypersensitivity in Retreatment Gynecologic Cancer Patients
TCTR20151123001Active, not recruiting
- Start
- Jun 2015
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of carboplatin in gynecological cancer (2 arms), sponsored by none. Primary endpoint: Incidence of carboplatin hypersensitivity reactions. Started Jun 2015; status: active, not recruiting.
02
Drugs
carboplatin
03
Conditions
gynecological cancer
Beyond the preview
Go deeper on TCTR20151123001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20151123001.